AlphaCrest Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,419
| Closed | -$84K | – | 1359 |
|
|
2022
Q1 | $84K | Buy |
14,419
+2,919
| +25% | +$17K | ﹤0.01% | 1220 |
|
|
2021
Q4 | $86K | Buy |
11,500
+968
| +9% | +$7.24K | ﹤0.01% | 1347 |
|
|
2021
Q3 | $95K | Sell |
10,532
-23,052
| -69% | -$208K | ﹤0.01% | 1226 |
|
|
2021
Q2 | $402K | Buy |
33,584
+15,253
| +83% | +$183K | 0.02% | 1027 |
|
|
2021
Q1 | $230K | Sell |
18,331
-19,112
| -51% | -$240K | 0.01% | 1101 |
|
|
2020
Q4 | $584K | Sell |
37,443
-94,141
| -72% | -$1.47M | 0.05% | 567 |
|
|
2020
Q3 | $1.24M | Buy |
131,584
+100,584
| +324% | +$950K | 0.14% | 194 |
|
|
2020
Q2 | $278K | Buy |
+31,000
| New | +$278K | 0.05% | 667 |
|
|
2020
Q1 | – | Sell |
-10,200
| Closed | -$85K | – | 1250 |
|
|
2019
Q4 | $85K | Buy |
+10,200
| New | +$85K | 0.01% | 1229 |
|